Investment

Details

Screening project between Takeda and MMV
  • RFP Year
    2019
  • Awarded Amount
    $41,962
  • Disease
    Malaria
  • Intervention
    Drug
  • Development Stage
    Hit Identification
  • Collaboration Partners
    Takeda Pharmaceutical Company Limited, Medicines for Malaria Venture (MMV)